1261914

Michael J. Downing, M.D. — FEI 3014256731

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)